Infertility is a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse. In a couple, there are different reasons for infertility, with decreased egg quality and reserve being recognised as the most important factor for determining the success of pregnancy.
The aim of the project is to develop and globaly introduce OvaRenew, capsule for restoration of the impaired egg quality and quantity in woman with ovarian insufficiency, as a first-line therapy. Our solution is based on new disruptive findings of stem cells in ovaries that are able to transform into oocytes under defined conditions. We tend to prove, that those conditions can be initiated through the substances, administered orally.